David Sheyn, MD (he/him/his)

Associate Professor of Urology and Reproductive Biology Division Director, Female Pelvic Medicine and Reconstructive Surgery
University Hospitals System Urology Institute
Pepper pike, Ohio, United States

David Sheyn, MD, is Associate Professor of Urology and Reproductive Biology at Case Western Reserve University and Division Director of Female Pelvic Medicine and Reconstructive Surgery at the University Hospitals Urology Institute in Cleveland, Ohio. Dr. Sheyn completed a four-year residency in obstetrics and gynecology and three-year fellowship in female pelvic medicine and reconstructive surgery in the Department of Urology, both at University Hospitals. His research interests include the application of artificial intelligence methodology to diagnosis, prognosis, and treatment of pelvic floor disorders and the determination of the etiology of overactive bladder syndrome phenotypes. He is a graduate of the UrogynCREST program and is the recipient of several public and industry sponsored grants.

Presentation(s):

• Effect of Route of Hysterectomy on Cost in a National Sample

  Thursday, October 5, 2023
  12:14 PM – 12:18 PM US PST

  Disclosure(s): Axonics: Clinical Trial Investigator (Ongoing); Caldera Medical: Advisor (Ongoing), Advisor (Ongoing), Advisor (Ongoing); CollaMedix: Consultant/Advisory Board (Ongoing), Stock-privately held company (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing); Renalis: Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing)

• Comparing 3-year outcomes between staged vs full sacral neuromodulation implants

  Thursday, October 5, 2023
  2:15 PM – 2:19 PM US PST

  Disclosure(s): Axonics: Clinical Trial Investigator (Ongoing); Caldera Medical: Advisor (Ongoing), Advisor (Ongoing), Advisor (Ongoing); CollaMedix: Consultant/Advisory Board (Ongoing), Stock-privately held company (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing); Renalis: Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing)

• 1-year Outcomes Following Bulking or Sling at the Time of Pelvic Organ Prolapse Repair

  Thursday, October 5, 2023
  4:00 PM – 4:04 PM US PST

  Disclosure(s): Axonics: Clinical Trial Investigator (Ongoing); Caldera Medical: Advisor (Ongoing), Advisor (Ongoing), Advisor (Ongoing); CollaMedix: Consultant/Advisory Board (Ongoing), Stock-privately held company (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing); Renalis: Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing)

• Perioperative Tamsulosin for Prevention of Urinary Retention After Midurethral Sling Placement

  Friday, October 6, 2023
  12:30 PM – 12:34 PM US PST

  Disclosure(s): Axonics: Clinical Trial Investigator (Ongoing); Caldera Medical: Advisor (Ongoing), Advisor (Ongoing), Advisor (Ongoing); CollaMedix: Consultant/Advisory Board (Ongoing), Stock-privately held company (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing); Renalis: Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing)

• Cost Analysis of Robotic Assisted Laparoscopic Hysterectomy and Conventional Laparoscopic Hysterectomy

  Friday, October 6, 2023
  2:49 PM – 2:53 PM US PST

  Disclosure(s): Axonics: Clinical Trial Investigator (Ongoing); Caldera Medical: Advisor (Ongoing), Advisor (Ongoing), Advisor (Ongoing); CollaMedix: Consultant/Advisory Board (Ongoing), Stock-privately held company (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing); Renalis: Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing)

• Mini State of the Art: AI in Urogynecology

  Friday, October 6, 2023
  3:40 PM – 4:00 PM US PST

  Disclosure(s): Axonics: Clinical Trial Investigator (Ongoing); Caldera Medical: Advisor (Ongoing), Advisor (Ongoing), Advisor (Ongoing); CollaMedix: Consultant/Advisory Board (Ongoing), Stock-privately held company (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing); Renalis: Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing)